Are you Dr. Dentchev?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
960 S Columbia Rd Altru Cancer Center
Grand Forks, ND 58201Phone+1 701-780-5400Fax+1 701-780-6416
Summary
- Dr. Todor Dentchev, MD is an oncologist in Grand Forks, North Dakota. He is currently licensed to practice medicine in North Dakota, Minnesota, and Kansas. He is affiliated with Altru Health System.
Education & Training
- Brooklyn Hospital CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
- Brooklyn Hospital CenterResidency, Internal Medicine, 1994 - 1997
- Medical University of Sofia FOMClass of 1984
Certifications & Licensure
- ND State Medical License 2001 - 2026
- MN State Medical License 2012 - 2025
- MO State Medical License Active through 2013
- KS State Medical License 2011 - 2012
- ME State Medical License Active through 2003
- FL State Medical License 2001 - 2002
Clinical Trials
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2004 Dec 01
Publications & Presentations
PubMed
- 16 citationsOsteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8Ann E. Kearns, Donald W. Northfelt, Amylou C. Dueck, Pamela J. Atherton, Shaker R. Dakhil
Supportive Care in Cancer. 2010-03-01 - 51 citationsAlternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National...Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. O'Connell, David M. Nagorney
Journal of Clinical Oncology. 2010-02-10 - 64 citationsImmediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.Stephanie L. Hines, Betty A. Mincey, Todor Dentchev, Jeff A. Sloan, Edith A. Perez
Breast Cancer Research and Treatment. 2009-02-12